Invest now

Dr. Agarwal's Health Care share price

Balanced risk
  • 27%Low risk
  • 27%Moderate risk
  • 27%Balanced risk
  • 27%High risk
  • 27%Extreme risk
  • ₹552.00(-0.40%)
    November 12, 2026 15:25:57 PM IST
    • NSE
    • BSE
  • Vol : 107.44 K (NSE + BSE)
    Last 20 day avg : 258.49 K
Dr. Agarwal's Health Care is trading -0.40% lower at Rs 552.00 as compared to its last closing price. Dr. Agarwal's Health Care has been trading in the price range of 557.95 & 543.10. Dr. Agarwal's Health Care has given 9.01% in this year & 5.85% in the last 5 days. Dr. Agarwal's Health Care has TTM P/E ratio 88.77 as compared to the sector P/E of 30.07.There are 3 analysts who have initiated coverage on Dr. Agarwal's Health Care. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 54.74 Crores in its last quarter.Listed peers of Dr. Agarwal's Health Care include Apollo Hospitals Enterprise (-0.91%), Max Healthcare Institute (2.16%), Fortis Healthcare (-1.23%).The Mutual Fund holding in Dr. Agarwal's Health Care was at 14.18% in 30 Sep 2026. The MF holding has decreased from the last quarter. The FII holding in Dr. Agarwal's Health Care was at 34.52% in 30 Sep 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 13 Nov 2026, 05:24 AM IST

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.53
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    8.62
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
543.10
Highest
557.95
52 week range
Lowest
402.10
Highest
567.30
Dr. Agarwal's Health Care Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
8,511.50-0.911,22,382.3164.9313.390.2353.80
Max Healthcare Institute
945.002.1691,979.4171.479.870.1827.71
Fortis Healthcare
760.00-1.2357,376.8267.897.270.1029.68
Aster DM Healthcare
732.551.1763,934.66102.559.260.4944.74
Narayana Hrudayalaya
1,844.00-1.2137,605.8048.079.080.22121.59
Mutual Fund Ownership
View all
Motilal Oswal Small Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 145.66
  • % of AUM 2.96
Edelweiss Recently Listed IPO Fund Regular Plan Growth
NA
  • Amount Invested (Cr.) 26.07
  • % of AUM 2.91
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 2.05
  • % of AUM 2.42
Canara Robeco Focused Equity Fund Regular Growth
4/5
  • Amount Invested (Cr.) 48.81
  • % of AUM 1.87
Motilal Oswal Multi Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 62.37
  • % of AUM 1.62
Dr. Agarwal's Health Care Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-11-05Quarterly Results
2026-08-04Quarterly Results
2026-05-21Audited Results
2026-02-03Quarterly Results
2025-10-30Quarterly Results
About the company Dr. Agarwal's Health Care
  • IndustryHealthcare Facilities
  • ISININE943P01029
  • BSE Code544350
  • NSE CodeAGARWALEYE
Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.
  • Management Info
  • Adil AgarwalWhole Time Director, Chief Executive Officer
  • Anosh AgarwalWhole Time Director, Chief Operating Officer
  • Thanikainathan ArumugamVice President - Corporate Affairs, Company Secretary, Compliance Officer
Dr. Agarwal's Health Care Share Price FAQs

Dr. Agarwal's Health Care is trading at 552.00 as on Thu Nov 12 2026 09:55:57. This is -0.40% lower as compared to its previous closing price of 554.20.

The market capitalization of Dr. Agarwal's Health Care is 17537.44 Cr as on Thu Nov 12 2026 09:55:57.

The average broker rating on Dr. Agarwal's Health Care is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Dr. Agarwal's Health Care is 567.30 whereas the 52 wk low is 402.10

Dr. Agarwal's Health Care can be analyzed on the following key metrics -

  • TTM P/E: 88.77
  • Sector P/E: 30.07
  • Dividend Yield: 0.00%
  • D/E ratio: 0.53

Dr. Agarwal's Health Care reported a net profit of 133.19 Cr in 2026.

The Mutual Fund Shareholding was 14.18% at the end of 30 Sep 2026.